Impact of certified CME in atrial fibrillation on administrative claims

American Journal of Managed Care

Volumn 18, Issue 5, 2012, Pages 253-260

  Stowell, Stephanie A ^a   Gardner, Allison J ^a   Alpert, Joseph S ^b   Naccarelli, Gerald V ^c   Harkins, Thomas P ^d   Louder, Anthony M ^d   Tamariz, Leonardo ^e  

^a Med IQ   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d Competitive Health Analytics Inc ^*  (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONTINUING EDUCATION; FEMALE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HUMAN; LENGTH OF STAY; MALE; MEDICAL EDUCATION; MEDICAL PRACTICE; PILOT STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ATRIAL FIBRILLATION; CLINICAL COMPETENCE; EDUCATION, MEDICAL, CONTINUING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH STATUS INDICATORS; HUMANS; INSURANCE CLAIM REVIEW; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 84864409287     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sanoski CA. Prevalence, pathogenesis, and impact of atrial fibrillation. Am J Health Syst Pharm. 2010;67(9)(suppl 5):S11-S16.
2. Wu EQ, Birnbaum HG, Mareva M, et al. Economic burden and comorbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin. 2005;21(10):1693-1699. (Pubitemid 41505035)
3. Ringborg A, Nieuwlatt R, Lindgren P, et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace. 2008;10(4):403-411. (Pubitemid 351767678)
4. Centers for Medicare & Medicaid Services. Quality initiatives - general information: overview. https://www.cms.gov/QualityInitiatives- GenInfo/. Accessed June 16, 2011.
5. National Quality Forum. NQF-Endorsed® Standards. http://qualityforum. org/Measures-List.aspx#. Accessed June 15, 2011.
6. Estes NA 3rd, Halperin JL, Calkins H, et al American College of Cardiology/American Heart Association Task Force on Performance Measures; Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation); Heart Rhythm Society. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/ American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society. Circulation. 2008;117(8):1101-1120.
7. Fuster V, Rydén LE, Cannom DS, et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [published correction appears in Circulation. 2007;116(6):e138]. Circulation. 2006;114(7):e257-354.
8. Accreditation Council for Continuing Medical Education. ACCME Standards for Commercial Support. http://www.accme.org/about-us/ accountability-to- thepublic/standards-commercial-support. Accessed November 22, 2011.
9. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation. 2003;108(6):711-716. (Pubitemid 36999256)
10. Torp-Pedersen C, Crijns HJ, Gaudin C, Page RL, Connolly SJ, Hohnloser SH; ATHENA Investigators. Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. Europace. 2011;13(8):1118-1126.
11. US Food and Drug Administration. FDA approves Multaq to treat heart rhythm disorder [FDA news release]. http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm170276.htm. Published July 2, 2009. Accessed November 22, 2011.
12. Wann LS, Curtis AB, January CT, et al ACCF/AHA Task Force Members. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2011;124(5):e173]. Circulation. 2011;123(1):104-123.
13. Kneeland PP, Fang MC. Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence. 2010;4:51-60.
14. Baker WL, Cios DA, Sander SD, Coleman CI. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm. 2009;15(3):244-252.
15. Walden PD, Dennison B, Jame C, et al. Administrative health data to assess performance in a myelodysplastic syndromes CME initiative. CE Measure. 2010;4(2):26-33.
16. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497. (Pubitemid 41127293)
17. Zeltser MV, Nash DB. Approaching the evidence basis for aviationderivedteamwork training in medicine. Am J Med Qual. 2010;25(1): 13-23.